Chair and CEO of Insmed Inc. (NASDAQ:INSM), recently executed a significant stock transaction amid the company's impressive 178% stock surge over the past year. According to a recent SEC filing, Lewis ...
Baird analyst Luke Junk lowered the firm’s price target on BorgWarner (BWA) to $34 from $36 and keeps a Neutral rating on the shares. The firm ...
BMO Capital analyst Andrew Strelzik raised the firm’s price target on Yum! Brands (YUM) to $139 from $135 and keeps a Market Perform rating on ...
Bristol-Myers Squibb beat Q4 earnings expectations, but the stock fell due to lowered 2025 revenue guidance and patent ...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...